Search Results - "José Ángel Díaz Arias"

Refine Results
  1. 1

    Prognostic Stratification of Multiple Myeloma Using Clinicogenomic Models: Validation and Performance Analysis of the IAC‐50 Model by Mosquera Orgueira, Adrián, González Pérez, Marta Sonia, Díaz Arias, José Ángel, Antelo Rodríguez, Beatriz, Mateos, María‐Victoria

    Published in HemaSphere (01-08-2022)
    “…A growing need to evaluate risk‐adapted treatments in multiple myeloma (MM) exists. Several clinical and molecular scores have been developed in the last…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5

    New Recurrent Structural Aberrations in the Genome of Chronic Lymphocytic Leukemia Based on Exome-Sequencing Data by Mosquera Orgueira, Adrián, Antelo Rodríguez, Beatriz, Díaz Arias, José Ángel, González Pérez, Marta Sonia, Bello López, José Luis

    Published in Frontiers in genetics (20-09-2019)
    “…Chronic lymphocytic leukemia (CLL) is the most frequent lymphoproliferative syndrome in Western countries, and it is characterized by recurrent large genomic…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9

    De novo drug design through artificial intelligence: an introduction by Crucitti, Davide, Pérez Míguez, Carlos, Díaz Arias, José Ángel, Fernandez Prada, Diego Beltrán, Mosquera Orgueira, Adrián

    Published in Frontiers in hematology (25-01-2024)
    “…Developing new drugs is a complex and formidable challenge, intensified by rapidly evolving global health needs. De novo drug design is a promising strategy to…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15

    Novel Mutation Hotspots within Non-Coding Regulatory Regions of the Chronic Lymphocytic Leukemia Genome by Mosquera Orgueira, Adrián, Rodríguez Antelo, Beatriz, Díaz Arias, José Ángel, Díaz Varela, Nicolás, Alonso Vence, Natalia, González Pérez, Marta Sonia, Bello López, José Luis

    Published in Scientific reports (12-02-2020)
    “…Mutations in non-coding DNA regions are increasingly recognized as cancer drivers. These mutations can modify gene expression in cis or by inducing high-order…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19

    A Three-Gene Expression Signature Identifies a Cluster of Patients with Short Survival in Chronic Lymphocytic Leukemia by Díaz Varela, Nicolás, Díaz Arias, José Ángel, Antelo Rodríguez, Beatriz, Mosquera Orgueira, Adrián, Bello López, José Luis

    Published in Journal of oncology (2019)
    “…Chronic lymphocytic leukemia (CLL) is a lymphoproliferative disorder characterized by its heterogeneous clinical evolution. Despite the discovery of the most…”
    Get full text
    Journal Article
  20. 20